We manufacture wide range of dosage forms complying to USFDA standard.
Our manufacturing facilities in Bandar Enstek provide robust business connectivity to the regional market, benefiting from a strategic location less than 5km away from Kuala Lumpur International Airport (KLIA).
Spanning over 12 acres of land, our manufacturing facilities were designed by an internationally renowned European pharma engineering firm, complying to USFDA, NPRA Malaysia and PIC/S regulatory requirements and undergoing GMP accreditation from EU and WHO Geneva.
Synergy is a finished products manufacturing facility based in Bandar Enstek, Negeri Sembilan to manufacture general pharmaceutical products.
Celsus is Southeast Asia’s FIRST fully automated, high containment (OEB5) finished products manufacturing facility for oncology products.
Galen is the FIRST Oncology API manufacturing facility in Southeast Asia.
Located in the heart of Uzbekistan's capital city of Tashkent, SYNERGY II was acquired as part of a long-term vision to Novugen's global presence. The facility has a capacity to cater to the whole CIS region and the neighbouring countries.
CELSUS II is the FIRST Oncology Finished Products manufacturing plant in Pakistan.
Our obsession for quality drives the company to achieve the highest standards for our products and services. This is aligned with our strategy and business philosophy to comply to USFDA and EU requirements through our day-to-day operations.
Our regulations and compliance systems assure pre-qualification of material vendors. We operate with stringent in-process system that provide control over any changes and documentation.